Henk Buck, a Dutch chemist who once claimed he could cure AIDS, is back, publishing a long explanation of why he was right all along in a journal by what Jeffrey Beall calls a possible predatory publisher. Buck spent a few months in 1990 as a hero. In April of that year, he and his team published … Continue reading After 25 years, AIDS fraud comes back swinging
Two major problems sunk this cancer paper. For one, many of the images were copied from another paper. In addition, one of the authors did not disclose that he was the president of a related company, nor that his company provided reagents for the experiments. It’s not clear when the paper was published, but The paper … Continue reading Conflict of interest, figure issues net retraction for cancer paper
The former director of the X-ray crystallography lab at the National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the National Institutes of Health, who was found by the Office of Research Integrity to have faked findings in three papers, is once again earning a government salary, this time as a patent examiner, Retraction … Continue reading Exclusive: Former NIH lab head who faked data now working as government patent examiner
A group of Chinese researchers has retracted a paper, saying that an outside lab switched their immunofluorescent stains with another research group’s. The group has decided to repeat the experiments on their own next time. Here’s the notice in Molecular Medicine Reports for “Protective role of Klotho on cardiomyocytes upon hypoxia/reoxygenation via downregulation of Akt and … Continue reading “Immorally” affecting the literature: Authors blame sloppy work from an outside lab for retraction
A former researcher at the University of Pittsburgh inflated the number of mice used in his experiments, and faked data in a number of images in a paper reporting the results, according to the Office of Research Integrity (ORI). Dong Xiao admitting to having intentionally fabricated data contained in a paper entitled ‘Guggulsterone inhibits prostate cancer growth … Continue reading Former Pitt cancer researcher admits to faking findings
PubPeer continues to make its mark on the scientific literature. Here’s another installment of PubPeer Selections:
A team led by David Latchman, a geneticist and administrator at University College London, has notched a mysterious retraction in the Journal of Biological Chemistry, and has had 25 more papers questioned on PubPeer. The JBC notice for “Antiapoptotic activity of the free caspase recruitment domain of procaspase-9: A novel endogenous rescue pathway in cell death” is as useless as they come, a … Continue reading Prominent geneticist nets retraction, two corrections, and a lot of questions
A postdoc at the Oklahoma Medical Research Foundation faked data in a submitted paper and in a grant application, according to a new report from the Office of Research Integrity. Bin Kang admitted to the misconduct, in which he
This week at Retraction Watch witnessed the fall of a “golden boy” and a “NASA Patriot Boy.” Here’s what was happening elsewhere:
A pair of cell biologists have taken responsibility for extensive figure errors that scuttled their paper in the Journal of Cell Biology. While there were five authors, first and last authors Eva Szabo and Michal Opas took responsibility in the notice. A number of figures “contain incorrect data and/or presentation errors,” and the original data isn’t available … Continue reading Fat cell paper earns unusually detailed retraction